Clinical trials
Osteoarthritis, Knee trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
98 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 10 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 8 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 66 |
| Unknown status | 13 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Valencia | 10 |
| GlaxoSmithKline | 4 |
| Bioiberica | 3 |
| Hospital Son Llatzer | 3 |
| Novartis Pharmaceuticals | 3 |
| Parc de Salut Mar | 3 |
| Tedec-Meiji Farma, S.A. | 3 |
| University of Castilla-La Mancha | 3 |
| Eli Lilly and Company | 2 |
| Novo Nordisk A/S | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoarthritis, Knee | 98 |
| Osteoarthritis | 29 |
| Pain | 13 |
| Osteoarthritis, Hip | 5 |
| Chronic Pain | 4 |
| Obesity | 4 |
| Joint Diseases | 3 |
| Musculoskeletal Diseases | 3 |
| Acute Pain | 2 |
| Knee Injuries | 2 |
Trials
Showing 76 to 98 of 98. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.